Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001226479 | SCV001398794 | uncertain significance | Saldino-Mainzer syndrome | 2022-07-12 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 1157 of the IFT140 protein (p.Gln1157Leu). This variant is present in population databases (rs772423904, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with IFT140-related conditions. ClinVar contains an entry for this variant (Variation ID: 954087). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002491715 | SCV002775990 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-05-16 | criteria provided, single submitter | clinical testing |